Skip to main content
SpringerLink
Log in

Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Two monoclonal antibodies (mAbs), designated MLuC5 and MLuC6, were produced against a human small cell lung carcinoma cell line. They were found to exhibit a superimposable reactivity on different cell lines and on platelets. Moreover, they both immunoprecipitated a 67 kDa molecule from the membrane of the reference target cells. Immunodepletion and cross-inhibition tests indicated that the two mAbs recognize two epitopes closely localized on the same molecule. The MLuC5 mAb was further characterized for its reactivity on platelets. Immunoprecipitation and ELISA assays demonstrate that this mAb recognizes the 67 kDa high afinity laminin receptor. MLuC5 reactivity was evaluated by immunohistochemistry on a variety of normal and tumor tissues, in particular breast specimens including normal epithelium, dysplastic lesions, in situ carcinomas, invasive primary carcinomas and distant metastases. The laminin receptor was found to be strongly expressed in 50% of the infiltrating carcinomas, whereas in situ carcinomas and benign lesions, as well as the normal mammary epithelium, were only weakly and focally positive. In metastatic lesions MLuC5 reactivity was only found in 11% of the samples tested, independently of the site of origin of the lesion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Engel J, Odermatt E, Engel A, Madri J, Furthmayr H, Rohde H and Timpl R, 1981, Shapes, domain organizations and flexibility of laminin, and fi bronectin, two multifunctional proteins of the extracellular matrix. Journal of Molecular Biology, 150, 97–120.

    Google Scholar 

  2. Timpl R, Engel J and Martin GR, 1983, Laminin: a multifunctional protein of basement membranes. Trends in Biochemistry, 8, 207–209.

    Google Scholar 

  3. Kleinman HK, Cannon FB, Laurie JR, Hassell JR, Aumailley M, Terranova VP, Martin GR and Dubois-Dalco M, 1985, Biological activities of laminin. Journal of Cell Biochemistry, 27, 317–325.

    Google Scholar 

  4. Rao CN, Barsky SH, Terranova VP and Liotta LA, 1983, Isolation of a tumor cell laminin receptor. Biochemical and Biophysical Research Communications, 111, 804–808.

    Google Scholar 

  5. Kleinman HK, Ogle RC, Cannon FB, Little CD, Sweeney TM and Luckenbill-Edds L, 1988, Laminin receptor for neurite formation. Proceedings of the National Cancer Institute of Academic Science, USA, 85, 1282–1286.

    Google Scholar 

  6. Graf J, Iwamoto Y, Sasaki M, Martin GR, Kleinman HK, Robey FA and Yamada Y, 1987, Identification of an amino acid sequence in laminin mediat ing cell attachment, chemotaxis and receptor binding. Cell, 48, 989–996.

    Google Scholar 

  7. Clément B, Segui-Real B, Savagner P, Kleinman HK and Yamada Y, 1990, Hepatocyte attachment to laminin is mediated through multiple receptors. Journal of Cell Biology, 110, 185–192.

    Google Scholar 

  8. Gelsen KR, Dillner L, Engvall E and Ruoslahti E, 1988, The human laminin receptor is a member of the integrin family of cell adhesion receptors. Science, 241, 1228–1229.

    Google Scholar 

  9. Smalheiser NR and Schwartz NB, 1987, Ranin: a laminin-binding protein of cell membranes. Proceedings of the National Cancer Institute of Academic Science, USA, 84, 6457–6461.

    Google Scholar 

  10. Hand PH, Thor A, Schlom J, Rao CN and Liotta LA, 1985, Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody. Cancer Research, 45, 2713–2719.

    Google Scholar 

  11. Mafune K, Ravikumar TS, Wong JM, Yow H, Chen LB and Steele GD, Jr, 1990, Expression of a M, 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression. Cancer Research, 50, 3888–3891.

    Google Scholar 

  12. Terranova VP, Rao CN, Kalebic T, Margulies IM and Liotta LA, 1983, Laminin receptor on human breast carcinoma cells. Proceedings of the National Cancer Institute of Academic Science, USA, 80, 444–448.

    Google Scholar 

  13. Barsky SH, Rao CN, Williams JE and Liotta LA, 1984, Laminin molecular domains which alter metastases in a murine model. Journal of Clinical Investigation, 74, 843–848.

    Google Scholar 

  14. Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y and Martin GR, 1987, YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastases. Science, 238, 1132–1134.

    Google Scholar 

  15. Sakamoto N, Iwahana M, Tanaka NG and Osada Y, 1991, Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2. Cancer Research, 51, 903–906.

    Google Scholar 

  16. Mënard S, Tagliabue E, Canevari S, Fossati G and Colnaghi MI, 1983, Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Research, 43, 1295–1300.

    Google Scholar 

  17. Miotti S, Canevari S, Ménard S, Mezzanzanica D, Porro G, Pupa SM, Regazzoni M, Tagliabue E and Colnaghi MI, 1987, Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. International Journal of Cancer, 39, 297–303.

    Google Scholar 

  18. Laemmli UK, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680–685.

    Google Scholar 

  19. Ey PL, Prowse SJ and Jenkins CR, 1978, Isolation of pure IgG1, IgG2 and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry, 15, 429–436.

    Google Scholar 

  20. Canevari S, Orlandi R, Ripamonti M, Tagliabue E, Aguanno A, Miotti S, Ménard S and Colnaghi MI, 1985, Ricin A chain conjugated to monoclonal anti bodies selectively kills human carcinoma cells in vitro. Journal of the National Cancer Institute, 75, 831.

    Google Scholar 

  21. Pellegrini R, Bazzini P, Tosi E, Tagliabue E, Conforti G, Dejana E, Ménard S and Colnaghi MI, 1992, Production and characterization of two monoclonal antibodies directed against the integrin β1 chain. Tumori, 78, 1–4.

    Google Scholar 

  22. Tandon NN, Holland EA, Kralisz U, Kleinman HK, Robey FA and Jamieson GA, 1991, Interaction of human platelets with laminin and identification of the 67 kDa laminin receptor on platelets. Biochemistry, 274, 535–542.

    Google Scholar 

  23. Pellegrini R, Centis F, Martignone S, Mastroianni A, Tagliabue E, Tosi E, Ménard S and Colnaghi MI, 1991, Characterization of a monoclonal antibody directed against the EGF-receptor binding site. Cancer Immunological Immunotherapy, 34, 37–42.

    Google Scholar 

  24. Mariani-Costantini R, Colnaghi MI, Leoni F, Ménard S, Cerasoli S and Rilke F, 1984, Immunohistochemical reactivities of a monoclonal antibody prepared against human breast carcinoma. Virchows Archives (A), 402, 389–404.

    Google Scholar 

  25. Tagliabue E, Martignone S, Mastroianni A, Ménard S, Pellegrini R and Colnaghi MI, 1991, Laminin receptors on SCLC cells. British Journal of Cancer, 63(Suppl.14), 83–85.

    Google Scholar 

  26. Daidone MG, Silvestrini R, D'Errico A, Di Fronzo G, Benini E, Mancini AM, Garbisa S, Liotta LA and Grigioni WF, 1991, Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. International Journal of Cancer, 48, 529–532.

    Google Scholar 

  27. Nakanishi Y, Cuttitta F, Kasprzyk PG, Treston AM, Avis IL, Minna JD, Kleinman HK and Mulshine JL. In: Rosen ST, Mulshine JL, Cuttitta JL and Abrams PG, eds. Biology of Lung Cancer pp. 69–89. New York: Decker, 1988.

    Google Scholar 

  28. Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF and Mulshine JL, 1990, Reconstituted basement membrane (Matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proceedings of the National Cancer Institute of Academic Science, USA, 87, 6698–6702.

    Google Scholar 

  29. van de Ouweland AMW, Van Duijnhoven HLP, Deichmann KA, Van Groningen JJM, Leij L and Van de Ven WJM, 1989, Characteristics of a multicopy predominantly consisting of processed pseudogenes. Nucleic Acids Research, 17, 3829–3824.

    Google Scholar 

  30. Elices MJ, Urry LA and Hemler ME, 1991, Receptor functions for the integrin VLA-3: fibronectin, collagen, and laminin binding are differentially influenced by Arg-Gly-Asp peptide and by divalent cations. Journal of Cell Biology, 112, 169–181.

    Google Scholar 

  31. Liotta LA, Rao CN and Barsky SH, 1983, Tumor invasion and the extracellular matrix. Laboratory of Investigation, 49, 639–649.

    Google Scholar 

  32. Yow H, Wong JM, Chen HS, Lee C, Steele G, Jr and Chen LB, 1988, Increased mRNA expression of a laminin-binding protein in human colon carcino mas: complete sequence of a full-length cDNA encoding the protein. Proceedings of the National Cancer Institute of Academic Science, USA, 85, 6394–6398.

    Google Scholar 

  33. Cioce V, Castronovo V, Shmookler BM, Garbisa S, Grigioni WF, Liotta LA and Sobel ME, 1990, Increased expression of the laminin receptor in human colon cancer. Journal of the National Cancer Institute, 83, 29–36.

    Google Scholar 

  34. Castronovo V, Colin C, Claysmith AP, Chen PHS, Lifrange E, Lambotte R, Krutzsch H, Liotta LA and Sobel ME, 1990, Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. American Journal of Pathology, 6, 1373–1381.

    Google Scholar 

  35. Castronovo V, Taraboletti G, Liotta LA and Sobel ME, 1989, Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. Journal of the National Cancer Institute, 81, 781–788.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oncologia Sperimentale E, Istituto Nazionale Tumori, Via Venezian 1, 20133, Milan, Italy

    S. Martignone, R. Pellegrini, E. Villa, A. Mastroianni, E. Tagliabue, S. Ménard & Maria I. Colnaghi

  2. Cell Biology Laboratory, American Red Cross, 20855, Rockville, MD, USA

    N. N. Tandon

Authors
  1. S. Martignone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Pellegrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Villa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. N. Tandon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Mastroianni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Tagliabue
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Ménard
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Maria I. Colnaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martignone, S., Pellegrini, R., Villa, E. et al. Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression. Clin Exp Metast 10, 379–386 (1992). https://doi.org/10.1007/BF00133466

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00133466

Keywords

Search

Navigation